Glial clusters and perineuronal glial satellitosis in the basal ganglia of neurofibromatosis type 1

Acta Neuropathologica

Volumn 116, Issue 1, 2008, Pages 57-66

  Yokota, Osamu ^a,b   Tsuchiya, Kuniaki ^a,c   Hayashi, Masaharu ^a   Kakita, Akiyoshi ^d   Ohwada, Kiyoshi ^e   Ishizu, Hideki ^b,f   Takahashi, Hitoshi ^d   Akiyama, Haruhiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e Aoyama Hospital   (Japan)

^f Zikei Institute of Psychiatry   (Japan)

Author keywords

Astrocyte; Cluster; Dysplasia; Neurofibromatosis type 1; Satellitosis

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; VIMENTIN;

AGED; AMNESIA; AMYGDALOID NUCLEUS; ARTICLE; ASTROCYTE; BASAL GANGLION; BRADYKINESIA; BRADYPHRENIA; CASE REPORT; CAUDATE NUCLEUS; CHILD; CLINICAL FEATURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; FEMALE; GAIT DISORDER; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROFIBROMATOSIS; NEUROPATHOLOGY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PUTAMEN; QUADRIPLEGIA; RESPIRATORY FAILURE; SATELLITE CELL; SCOLIOSIS; THALAMUS;

ADULT; AGED; AGED, 80 AND OVER; BASAL GANGLIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; NEUROGLIA;

EID: 47749145310     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-008-0390-2     Document Type: Article

References (27)

1. Astrom KE, Mancall EL, Richardson EP Jr (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 81:93-111. doi: 10.1093/ brain/81.1.93
2. Bajenaru ML, Donahoe J, Corral T, Reilly KM, Brophy S, Pellicer A et al (2001) Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 33:314-323. doi:10.1002/1098-1136(20010315)33:4≤314::AID-GLIA1030≥3.0.CO;2-Q
3. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME et al (1999) Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176. doi: 10.1126/science.286.5447.2172
4. Creange A, Zeller J, Rostaing-Rigattieri S, Brugieres P, Degos JD, Revuz J et al (1999) Neurological complications of neurofibromatosis type 1 in adulthood. Brain 122:473-481. doi: 10.1093/brain/122.3.473
5. Dasgupta B, Dugan LL, Gutmann DH (2003) The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J Neurosci 23:8949-8954
6. Dasgupta B, Gutmann DH (2005) Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci 25:5584-5594. doi: 10.1523/JNEUROSCI.4693-04.2005
7. DiMario FJ Jr, Ramsby G (1998) Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 55:500-505. doi: 10.1001/archneur.55.4.500
8. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT (1995) Neurofibromatosis type 1: Pathologic substrate of high-signal-intensity foci in the brain. Radiology 195:721-724
9. Donegani G, Grattarola FR (1973) Tuberous sclerosis. Bourneville disease. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 14. The phacomatoses. North-Holland Publishing Company, Amsterdam, pp 340-389
10. Furuta A, Takashima S, Yokoo H, Rothstein JD, Wada K, Iwaki T (2005) Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. Brain Res Dev Brain Res 155:155-164. doi: 10.1016/j.devbrainres.2005.01.005
11. Goldstein SM, Curless RG, Donovan Post MJ, Quencer RM (1989) A new sign of neurofibromatosis on magnetic resonance imaging of children. Arch Neurol 46:1222-1224
12. Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Mason G, Cheung S (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: A proliferative potential? Pediatrics 104:e49. doi: 10.1542/peds.104.4.e49
13. Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18:4450-4459. doi: 10.1038/sj.onc.1202829
14. Gutmann DH, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF (2001) Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 10:3009-3016. doi: 10.1093/hmg/10.26.3009
15. Huson SM, Compston DA, Clark P, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in southeast Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704-711
16. Kato M, Takashima S, Houdou S, Miyahara S (1995) Cerebellar leptomeningeal astroglial heterotopia in neurofibromatosis type 1. Clin Neuropathol 14:175-178
17. National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575-578
18. Nordlund ML, Rizvi TA, Brannan CI, Ratner N (1995) Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol 54:588-600. doi: 10.1097/00005072-199507000-00013
19. Rakhade SN, Loeb JA (2008) Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 49:226-236. doi: 10.1111/j.1528-1167.2007.01310.x
20. Rizvi TA, Akunuru S, de Courten-Myers G, Switzer RC 3rd, Nordlund ML, Ratner N (1999) Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. Brain Res 816:111-123. doi: 10.1016/S0006-8993(98)01133-0
21. Rosman NP, Pearce J (1967) The brain in multiple neurofibromatosis (von Recklinghausen's disease): A suggested neuropathological basis for the associated mental defect. Brain 90:829-838. doi: 10.1093/brain/90.4.829
22. Rubinstein LJ (1986) The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases. Ann N Y Acad Sci 486:14-29. doi: 10.1111/j.1749-6632.1986.tb48058.x
23. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF (1999) Mouse tumor model for neurofibromatosis type 1. Science 286:2176-2179. doi: 10.1126/science.286.5447.2176
24. Walker AE (1941) Astrocytosis arachnoideae cerebelli. A rare manifestation of von Recklinghausen's neurofibromatosis. Arch Neurol Psychiatry 45:520-532
25. Yokota O, Tsuchiya K, Oda T, Ishihara T, de Silva R, Lees AJ et al (2006) Amyotrophic lateral sclerosis with dementia: An autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration. Acta Neuropathol 112:633-645. doi: 10.1007/s00401-006-0141-1
26. Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M et al (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: A comparative clinicopathological study. Acta Neuropathol 115:561-575. doi: 10.1007/s00401-007-0329-z
27. Zhu Y, Harada T, Liu L, Lush ME, Guignard F, Harada C et al (2005) Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development 132:5577-5588. doi: 10.1242/dev.02162